Skip to content

Clinical trials

Stomach Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Country / region: Japan Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20025
20032
20045
20057
20065
20074
20088
20096
20103
201110
20124
20135
20146
20153
20167
20177
201813
20194
20208
202111
202213
202310
20247
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Recruiting29
Active, not recruiting22
Terminated20
Unknown status15
Suspended2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
Pfizer10
Amgen9
Eli Lilly and Company6
Taiho Pharmaceutical Co., Ltd.6
Japan Clinical Oncology Group5
Merck Sharp & Dohme LLC5
Novartis Pharmaceuticals5
Ono Pharmaceutical Co., Ltd.5
Seagen, a wholly owned subsidiary of Pfizer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms178
Carcinoma, Non-Small-Cell Lung22
Esophageal Neoplasms21
Neoplasms15
Colorectal Neoplasms14
Ovarian Neoplasms14
Breast Neoplasms13
Squamous Cell Carcinoma of Head and Neck13
Endometrial Neoplasms11
Neoplasm Metastasis11

Trials

Showing 51 to 75 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.